Jazz Pharmaceuticals (JAZZ) News Today $109.46 +1.39 (+1.29%) Closing price 04:00 PM EasternExtended Trading$110.26 +0.80 (+0.73%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock JAZZ Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Woodline Partners LP Sells 201,644 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Woodline Partners LP cut its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 72.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 77,564 shares of the speciMay 25 at 4:41 AM | marketbeat.comTwo Sigma Advisers LP Has $10.06 Million Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Two Sigma Advisers LP lessened its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 22.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 81,700 shares of the specialty pharmaceutical company's stocMay 25 at 4:32 AM | marketbeat.comCetera Investment Advisers Buys New Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Cetera Investment Advisers bought a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 10,092 shares of the specialty pharmaceutical company's stock, valued at apMay 25 at 3:29 AM | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Two Sigma Investments LPTwo Sigma Investments LP decreased its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 41.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 187,126 shares of the specMay 24 at 4:45 AM | marketbeat.comTidal Investments LLC Boosts Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Tidal Investments LLC boosted its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 14.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,905 shares of the specialty pharmaceutiMay 24 at 4:45 AM | marketbeat.comMan Group plc Has $3.33 Million Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Man Group plc raised its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 22.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 27,075 shares of the specialty pharmaceutical company's stock after buyingMay 24 at 4:13 AM | marketbeat.comMidWestOne Financial Group Inc. Grows Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)MidWestOne Financial Group Inc. lifted its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 10.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 24,347 shares of the specialty pharmaceuticalMay 23, 2025 | marketbeat.comNomura Holdings Inc. Increases Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Nomura Holdings Inc. grew its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 218.3% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 8,022 shares of the specialty pharmaceutical company's stock after buying an additional 5,502 shares dMay 22, 2025 | marketbeat.comFocus Partners Wealth Buys Shares of 4,469 Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Focus Partners Wealth bought a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 4,469 shares of the specialty pharmaceutiMay 22, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Position Cut by Cubist Systematic Strategies LLCCubist Systematic Strategies LLC decreased its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 98.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 449 shares of the specialty pharmaceutical company's stockMay 22, 2025 | marketbeat.comJazz Pharmaceuticals to Participate in Upcoming June Investor ConferencesMay 21, 2025 | prnewswire.comVestal Point Capital LP Boosts Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Vestal Point Capital LP lifted its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 8.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 975,000 shares of the specialty pharmaceutical company's stock after buying an additiMay 21, 2025 | marketbeat.comPoint72 Asset Management L.P. Sells 184,632 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Point72 Asset Management L.P. trimmed its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 68.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 84,151 shares of the specialty pharmaMay 21, 2025 | marketbeat.comJazz Pharmaceuticals: One Step Forward, One BackMay 21, 2025 | seekingalpha.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Stake Raised by Nuveen Asset Management LLCNuveen Asset Management LLC grew its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 1.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 468,346 shares of the specialtyMay 21, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock Holdings Lessened by Stonepine Capital Management LLCStonepine Capital Management LLC reduced its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 81.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 10,000 shares of the specialty pharmaceutical company's stock after selliMay 20, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Strategic Global Advisors LLCStrategic Global Advisors LLC reduced its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 34.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,342 shares of the specialty pharmaceutiMay 20, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. trimmed its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 5.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 61,079 shares of the specialty pharmaceutical compMay 20, 2025 | marketbeat.comJAZZ Q1 Earnings Call: Revenue and Profit Miss, Product Pipeline Drives OutlookMay 20, 2025 | msn.comSystematic Financial Management LP Acquires 92,336 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Systematic Financial Management LP lifted its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 32.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 376,313 shares of the specialty pharmaceutical companyMay 19, 2025 | marketbeat.comRaiffeisen Bank International AG Buys Shares of 9,564 Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Raiffeisen Bank International AG bought a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 9,564 shares of the specialty pharmaceutical company's stock, valued aMay 19, 2025 | marketbeat.comPoint72 Asia Singapore Pte. Ltd. Decreases Stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Point72 Asia Singapore Pte. Ltd. cut its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 85.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,117 sharesMay 19, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Gotham Asset Management LLCGotham Asset Management LLC lowered its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 28.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 15,091 shares of the specialty pharmaceutical company's stock after selling 5May 19, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by OMERS ADMINISTRATION CorpOMERS ADMINISTRATION Corp cut its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 34.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,392 shares of the specialty pharmaceutical company's stock afteMay 18, 2025 | marketbeat.comQuantinno Capital Management LP Purchases 42,655 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Quantinno Capital Management LP boosted its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 72.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 101,568 shares of the specialty pharmaceutical company's stock after purchasinMay 17, 2025 | marketbeat.comJazz Pharmaceuticals (NASDAQ:JAZZ) Cut to "Hold" at StockNews.comStockNews.com cut shares of Jazz Pharmaceuticals from a "buy" rating to a "hold" rating in a report on Thursday.May 17, 2025 | marketbeat.comJazz Pharmaceuticals (NASDAQ:JAZZ) Stock Rating Lowered by StockNews.comMay 17, 2025 | americanbankingnews.comParkman Healthcare Partners LLC Has $4.65 Million Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Parkman Healthcare Partners LLC decreased its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 47.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 37,751 shares of the specialty pharmaceutical company's stock after selling 34,505May 16, 2025 | marketbeat.comLighthouse Investment Partners LLC Purchases New Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Lighthouse Investment Partners LLC purchased a new stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 24,500 shares of the sMay 16, 2025 | marketbeat.com48,994 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Bought by McGowan Group Asset Management Inc.McGowan Group Asset Management Inc. purchased a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund purchased 48,994 shares of the specialty pharmaceutical company's stock, valued at approximately $6,034,00May 15, 2025 | marketbeat.comMubadala Investment Co PJSC Takes $2.46 Million Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Mubadala Investment Co PJSC acquired a new stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 20,003 shares of the specialty pharmaceutical company'sMay 15, 2025 | marketbeat.comBank of America Corp DE Sells 35,641 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Bank of America Corp DE lessened its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 5.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 591,344 shares of the specialty pharmaceuticMay 15, 2025 | marketbeat.comMajor Purchase Alert: Seamus Mulligan Invests $9.99M In Jazz Pharmaceuticals StockMay 14, 2025 | benzinga.comPharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs PeersMay 14, 2025 | finance.yahoo.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Director Seamus Mulligan Buys 1,621 SharesMay 14, 2025 | insidertrades.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Acquired by D. E. Shaw & Co. Inc.D. E. Shaw & Co. Inc. raised its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 16.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 302,109 shares of the specialty pharmMay 13, 2025 | marketbeat.comDZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Sells 8,026 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main decreased its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 31.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. TheMay 13, 2025 | marketbeat.comFrontier Capital Management Co. LLC Acquires 11,027 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Frontier Capital Management Co. LLC lifted its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 46.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 35,002 shares of the specialty pharmaceuMay 12, 2025 | marketbeat.comCresset Asset Management LLC Sells 16,606 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Cresset Asset Management LLC lowered its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 49.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 16,843 shares of the specialty pharmaceutical company's stock after selling 16,606May 12, 2025 | marketbeat.comAlgert Global LLC Acquires Shares of 13,655 Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Algert Global LLC bought a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 13,655 shares of the specialty pharmaceutical company's stock, vaMay 12, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock Holdings Cut by Estuary Capital Management LPEstuary Capital Management LP reduced its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 11.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 232,517 shares of the specialty pharmaceutiMay 11, 2025 | marketbeat.comCrestline Management LP Has $1.06 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Crestline Management LP reduced its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 64.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,625 shares of the specialty pharmaceuticMay 11, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Get Free Report) have been given an average rating of "Moderate Buy" by the fourteen brokerages that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buyMay 10, 2025 | marketbeat.comJazz Pharmaceuticals plc Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting NowMay 9, 2025 | uk.finance.yahoo.comPharma Stock Roundup: NVO & JAZZ's Q1 Results, AZN's Pipeline UpdateMay 9, 2025 | msn.comJazz Pharmaceuticals (NASDAQ:JAZZ) Shares Gap Down on Disappointing EarningsJazz Pharmaceuticals (NASDAQ:JAZZ) Shares Gap Down Following Weak EarningsMay 9, 2025 | marketbeat.comMorgan Stanley Issues Pessimistic Forecast for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock PriceMorgan Stanley dropped their price target on Jazz Pharmaceuticals from $183.00 to $166.00 and set an "overweight" rating on the stock in a research note on Wednesday.May 9, 2025 | marketbeat.comJazz Pharmaceuticals (NASDAQ:JAZZ) Receives "Buy" Rating from Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $200.00 price objective on shares of Jazz Pharmaceuticals in a report on Wednesday.May 9, 2025 | marketbeat.comAxa S.A. Acquires Shares of 38,543 Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Axa S.A. bought a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 38,543 shares of the specialty pharmaceutical company's stock, vaMay 9, 2025 | marketbeat.comNorthern Trust Corp Raises Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Northern Trust Corp raised its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 18.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 521,196 shares of the specialty pharmaceuMay 9, 2025 | marketbeat.com Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address JAZZ Media Mentions By Week JAZZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JAZZ News Sentiment▼1.421.03▲Average Medical News Sentiment JAZZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JAZZ Articles This Week▼1612▲JAZZ Articles Average Week Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RPRX News CORT News PRGO News SUPN News PCRX News OMER News NKTR News ASMB News CPIX News LLY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JAZZ) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy JAZZ Stock Free JAZZ Stock Alerts